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A B S T R A C T
Pituitary tumors are rare tumors (less then 10%) of the central nervous system (CNS), which malignicity depends on
their localization, meanwhile, their biological nature is benign. The diameter they have is mostly less then 10 mm (mi-
croadenomas), but sometimes could be 10 mm (macroadenomas) to 5 cm and more and then are usually nonfunctional
(about 20% of all pituitary tumors). Clinical presence depends on their localisation and hormonal activity. In the Center
for Clinical Neuroendocrinology and Pituitary Diseases, in the last working 10 years, there were treated and examined
504 patients from Croatia, all with pituitary tumors: 182 patients with prolactinomas, 137 with acromegaly, 70 with
Morbus Cushing (Mb. Cushing), and 115 patients with nonfunctional pituitary tumors. The patient's classification is
based on regional (Mediterranean and continental region, 20 counties) and the state level. In our analysis we haven't
found difference in incidence of tumors between Mediterranean and continental region.
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Introduction
A large number of diseases may affect the pituitary,
the most frequent are benign tumors or adenomas that
are either hormonally functional or nonfunctional, mak-
ing up more then 90% of all pituitary neoplasms. Also, we
can divided them into microadenomas (<10 mm in diam-
eter) and macroadenomas (>10 mm in diameter). They
are frequently occurring tumors representing approxi-
mately 15% or even more of the operated intracranial
neoplasms. Studies using unselected adult autopsy mate-
rial show that pituitary adenomas can be incidentally
identified in approximately 20% of men and women dy-
ing of different non-endocrine diseases. These results in-
dicate that in North America millions of adults harbor
adenomas in their pituitaries. Most of these tumors are
small, unassociated with clinical symptoms and usually
of no significance. Many pituitary adenomas secrete vari-
ous hormones in excess and are associated with elevated
blood hormone levels as well as different endocrine signs
and symptoms. Several pituitary nonfunctional adenom-
as are unassociated with increased blood hormone levels
and endocrine alterations. These tumors, if they reach a
large size, can cause local symptoms1–3.
About 40% of these small tumors produce prolactin
(PRL), the remaining ones most likely secrete other pep-
tides or proteins whose biologic function is obscure.
Hyperprolactinaemia is the most common pituitary
disorder, and the prolactinoma is the most common pitu-
itary tumor. Prolactin-producting tumors exist ''silently''
in up to 5–10% of population. In both sexes prolac-
tinomas are the most common secretory tumors of the pi-
tuitary, producing excessive quantities of prolactin4.
Clinically significant prolactinoma affects the health
subjects approximately 14 out of 100,000 individuals.
The majority of tumors in women are microadenomas
(<10 mm in diameter), but in a small percentage there
are macroadenomas (>10 mm) at the time of diagnosis.
The frequency of microadenomas is much lower in men,
perhaps because of later recognition5–8.
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Acromegaly is a serious systemic condition caused in
over 98% of cases by a well-demarcated acidophilic or
chromophobic growth hormone- secreting adenoma lo-
cated in the anterior lobe of the pituitary gland that se-
crete excessive growth hormone (GH). The classification
of GH-secreting pituitary tumors, based on their hor-
monal content, ultrastructural features, and cytogenesis
includes densely and sparsely granulated GH cell ad-
enomas, mixed GH and PRL cell adenomas, acidophil
stem cell adenomas, mammosomatotroph cell adenomas,
plurihormonal adenomas and GH cell carcinomas. It is
relatively uncommon disease, which has been estimated
to affect about 40 cases per million. An annual incidence
of 3 cases per million has been estimated in English and
Swedish surveys. A recent epidemiologic study, perform-
ed in Italy, confirmed a prevalence of 42 cases per million,
and an annual incidence of 3.3 cases per million. There is
a slight preponderance of women, and the onset of the
disease is more frequent between the third and the fifth
decades. Growth hormone-secreting pituitary tumors ge-
nerally growmore rapidly in patients younger then 359–11.
Cushing's disease affects 10 to 15 of every million peo-
ple every year, and most commonly affects adults aged
between 20 to 50 years. Incidence is 0.1 to 1 new clini-
cally case per year. Women account for over 70% of cases,
and the ratio between men and women is from 3:1 to
10:1. Children in Morbus Cushing (Mb. Cushing) partici-
pate in 30% and mostly are older then 9 years, with
similar sex distribution. Patients with Cushing's disease
may have a basophilic adenoma of the pituitary or a chro-
mophobic adenoma. The cause of Cushing's syndrome is
a pituitary adenoma in over 70% of adults and in approxi-
mately 60–70% of children and adolescents. Most pituitary
adrenocorticotropic- secreting adenomas are small in
size (microadenoma)12,13.
Nonfunctional tumors of intra- or parasellar region
are craniopharyngiomas, meningiomas, hamartomas,
gliomas, germinomas and nonfunctional hypophiseal ad-
enomas. They are usually not discovered until they press
on important structures around them. For this reasons,
although they are almost always benign tumors, they are
frequently quite large when detected, ranging from an
average of about one inch across to more than four
inches. Nonfunctional pituitary adenomas participate in
25–30% of all hypophiseal adenomas. Craniopharyngio-
mas are intracranial tumors that can occur at any age,
most commonly in childhood and adolescence and in
later adult life, after 50 years. The median age is 22
years. They account for about 10% of CNS tumors in
these younger age groups and 2 to 4% of primary brain
tumors. There is similar classification among sexes. Hy-
pothalamic hamartomas are not true neoplasms, but
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TABLE 1
THE PITUITARY TUMORS SEPARATED BY TUMOR TYPE AND COUNTIES IN CROATIA
County
Cushing Prolactinoma Acromegaly Nonfunctional Total
N % N % N % N % N %
1. Zagreba~ka
2. Krapinsko-zagorska
3. Sisa~ko-moslava~ka
4. Karlova~ka
5. Vara`dinska
6. Koprivni~ko-kri`eva~ka
7. Bjelovarsko-bilogorska
8. Primorsko-goranska
9. Li~ko-senjska
10. Viroviti~ko-podravska
11. Po`e{ko-slavonska
12. Brodsko-posavska
13. Zadarska
14. Osje~ko-baranjska
15. [ibensko-kninska
16. Vukovarsko-srijemska
17. Splitsko-dalmatinska
18. Istarska
19. Dubrova~ko-neretvanska
20. Me|imurska
12
4
6
6
1
2
2
1
1
4
1
2
5
2
0
5
8
3
1
4
6
16
35
23
13
22
40
25
25
49
7
18
22
9
0
26
12
27
10
40
87
12
4
5
2
3
3
2
0
3
3
3
7
8
6
5
19
6
2
2
42
48
24
19
25
34
60
50
0
38
21
27
31
36
60
26
30
55
20
20
50
8
6
7
2
2
0
1
2
1
7
1
7
7
1
6
19
2
4
4
25
32
35
27
25
22
0
25
50
13
51
9
30
32
10
32
29
18
40
40
54
1
1
8
3
2
0
0
1
0
3
5
4
5
3
3
19
0
3
0
27
4
6
31
37
2
0
0
25
0
21
46
17
23
30
16
29
0
30
0
203
25
17
26
8
9
5
4
4
8
14
11
23
22
10
18
65
11
10
10
40
5
3
5
1.6
1.8
0.9
0.8
0.8
1.6
2.8
2.2
4.6
4.4
2
3.6
13
22
2
2
TOTAL 70 14 182 36 137 27 115 23 504 100
Mediterranean 19 37.25 42 30 36 35.64 30 35.29 128 33.78
Continental 51 62.75 140 70 101 64.36 85 64.71 376 66.22
rather congenital malformations, mostly discovered in
age before 2 years (69.8%), 2 to 4 years (17.5%) and 5 to 8
years (7.9%). They occure in men in 55.4% and in women
in 44.6% of cases. Meningiomas arise in the presellar and
parasellar region, usually occurring in adult women in
age between 40 and 50 years. The ratio between men and
women is 3:1. Optic chiasm gliomas usually occur in
children14.
Frequent monitoring of endocrine status and evalua-
tion of the sella turcica, at least yearly, are indicated for
the remainder of a patient's life following therapy of a
macroadenoma15.
Subjects and Methods
In Center for Clinical Neuroendocrinology and Pitu-
itary diseases, University Hospital ''Sestre milosrdnice'',
Zagreb, there have been analyzed and cured 504 patients
with pituitary tumor in total in the last working 10
years. The patients from the Republic of Croatia have
been cured in Center (Table 1):
• 182 patients with prolactinomas
• 137 patients with acromegaly
• 70 patients with Cushing's disease
• 115 patients with non-functional pituitary tumors.
All patients have been analyzed by tumor type. The
regional pituitary tumor incidence is analyzed by solitary
regions and the whole territory of Republic of Croatia.
All regions are also analyzed based on the Mediterranean
and continental position (Table 1, Figure 1).
Continental Croatia: County of Zagreb, County of
Krapina-Zagorje, County of Sisak-Moslavina, County of
Karlovac, County of Vara`din, County of Koprivnica –
Kri`evci, County of Bjelovar-Bilogora, County of Virovi-
tica-Podravina, County of Po`ega-Slavonia, County of
Slavonski Brod-Posavina, County of Osijek-Baranja, Co-
unty of Vukovar-Srijem and County of Me|imurje.
Mediterranean Croatia: County of Split-Dalmatia,
County of Istria, County of Dubrovnik-Neretva, County
of Zadar and County of [ibenik-Knin.
Results
The largest account of Cushing's disease is found in
Count of Viroviti~ko-Podravska (49%), the smallest ac-
count in [ibensko-Kninska County (0%).
The largest account of prolactinomas is in Bjelovar-
sko-Bilogorska and [ibensko-Kninska County (60%) and
the smallest in Li~ko-Senjska County (0%).
Acromegaly is the leading pituitary tumor in Li~ko-
Senjska (50%) and almost never found in Bjelovarsko-
Bilogorska County (0%).
The largest account of non-functional tumors is in
Brodsko-Posavska County (46%), and the smallest in
Bjelovarsko-Bilogorska, Primorsko-Goranska, Viroviti~ko-
-Podravska, Istarska and Me|imurska County.
In total, the largest number of tumors is numbered in
Zagreba~ka county (203, or 40%), because there is the
largest number of inhabitants. Primorsko-Goranska and
Li~ko-Senjska County had the smallest percent of tu-
mors (4 or 0.8%), because there is the smallest number of
inhabitants.
Also, based on our documents, in Croatia the prolacti-
nomas are the leading pituitary tumor (36%). Acrome-
galy is on the second place (27%), non-functional tumors
are on the third place (23%) and Cushing's disease is the
last (14%, Figure 2).
These results, compared to worldwide published re-
sults, show the same incidence of pituitary tumors in
Croatia and the world itself.
We didn't separate the patients only according to
counties. We separate them on the regional base: Medi-
terranean (coast) and continental Croatia, to see if the
natural conditions and different life style (including food,
water, or war events) have any impact on appearance of
pituitary tumors. These two groups showed very similar
results. In Mediterranean region of Croatia there were
found 127 patients with pituitary tumors; Cushing's dis-
ease had 19 (15%), prolactinoma 42 (34%), acromegaly 36
(28%) and nonfunctional tumor 30 (23%) patients (Table
2, Figure 3).
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Fig. 1. Mediterranean and Continental regions in Republic
of Croatia.
Fig. 2. Representation of pituitary tumors in Croatia.
Nonfunct. – nonfunctional.
In Continental region of Croatia there were found 377
patients with pituitary tumors: 51 patient (14%) had
Cushing's disease, prolactinoma 140 (37%), acromegaly
101 (27%) and nonfunctional tumor 85 (22%) patients
(Table 3, Figure 4).
Parallels among incidence, tumor type and regional
distribution between pituitary tumors were also showed
(Figure 5).
Conclusion
Our results show that there is no statistically signifi-
cant difference among presentation of pituitary tumors
between this two main regions: Continental and Medi-
terranean part of Croatia. The difference is almost usu-
ally 1%. Our results are very similar to incidence of pitu-
itary tumors we found in literature. So, the natural and
life conditions have no impact on appearance of some
types of tumors. This is the largest center for evaluation
of pituitary tumors in Republic of Croatia, but small
number of patients is also evaluated in other hospitals.
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TABLE 2
PITUITARY TUMORS IN MEDITERRANEAN REGION OF CROATIA
Cushing Prolactinoma Acromegaly Nonfunctional TOTAL
N % N % N % N % N
19 15 42 34 36 28 30 23 127
Nonfunct. – nonfunctional
TABLE 3
PITUITARY TUMORS IN CONTINENTAL REGION OF CROATIA
Cushing Prolactinoma Acromegaly Nonfunctional TOTAL
N % N % N % N % N
51 14 140 37 101 27 85 22 377
Nonfunct. – nonfunctional
Fig. 3. Representation of pituitary tumors in Mediterranean
regions of Croatia. Nonfunct. – nonfunctional.
Fig. 4. Representation of pituitary tumors in continental
regions of Croatia. Nonfunct. – nonfunctional.
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REGIONALNA RA[IRENOST TUMORA HIPOFIZE U REPUBLICI HRVATSKOJ
S A @ E T A K
Tumori hipofize su rijetki tumori sredi{njeg `iv~anog sustava (manje od 10%) koji su maligni zbog svoje lokalizacije,
dok im je biolo{ka priroda benigna. Obi~no su manji od 10 milimetara (mikroadenomi), ali nekada su ve}i od 1 cm
(makroadenomi) pa i preko 5 centimetara i tada su obi~no funkcionalno nijemi (oko 20% svih hipofiznih tumora).
Klini~ka slika ovisi o sijelu tumora i hormonskoj aktivnosti. U Centru za klini~ku neuroendokrinologiju i bolesti hipo-
fize Klini~ke bolnice »Sestre milosrdnice« u zadnjih 10 godina obra|eno je i lije~eno ukupno 504 bolesnika: 182 boles-
nika s prolaktinskim tumorom, 137 s akromegalijom, 70 s Cushingovom bole{}u te 115 bolesnika s funkcionalnim
tumorom hipofize. Svi su bolesnici analizirani po regionalnoj pripadnosti (primorska i kontinentalna regija, 20 `upa-
nija) i na razini cijele Republike Hrvatske. Obradom nismo utvrdili razlike u u~estalosti pojave tumora hipofize izme|u
primorske i kontinentalne Hrvatske
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